Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115557) titled 'A Single-Arm, Multicenter Clinical Study of QL1706 Combined with XELOX as Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma' on Dec. 29, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Qilu Hospital of Shandong University (Qingdao)
Condition:
Gastric and Gastroesophageal Junction Adenocarcinoma
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-01-01
Target Sample Size: Treatment group:28;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=2...